Myovant Sciences Ltd. Total Liabilities and Equity
Myovant Sciences Ltd. had Total Liabilities and Equity of $403.52 million as of 2022-12-31, per its 10-Q filed 2023-01-26.
Discontinued › Balance Sheet
us-gaap:LiabilitiesAndStockholdersEquity · last filed 2023-01-26
- 2022-12-31: Liabilities and Equity $403.52M.
- 2022-09-30: Liabilities and Equity $483.97M.
- 2022-06-30: Liabilities and Equity $460.13M.
- 2022-03-31: Liabilities and Equity $520.01M.
| Period end | Liabilities and Equity |
|---|---|
| 2022-12-31 | $403.52M 10-Q · filed 2023-01-26 |
| 2022-09-30 | $483.97M 10-Q · filed 2022-10-26 |
| 2022-06-30 | $460.13M 10-Q · filed 2022-07-27 |
| 2022-03-31 | $520.01M 10-Q · filed 2023-01-26 |
| 2021-12-31 | $604.29M 10-Q · filed 2022-01-26 |
| 2021-09-30 | $679.54M 10-Q · filed 2021-10-26 |
| 2021-06-30 | $727.77M 10-Q · filed 2021-07-28 |
| 2021-03-31 | $725.03M 10-K · filed 2022-05-11 |
| 2020-12-31 | $774.21M 10-Q · filed 2021-02-11 |
| 2020-09-30 | $135.77M 10-Q · filed 2020-11-12 |
| 2020-06-30 | $126.68M 10-Q · filed 2020-08-11 |
| 2020-03-31 | $105.93M 10-K · filed 2021-05-11 |
| 2019-12-31 | $129.51M 10-Q · filed 2020-02-10 |
| 2019-09-30 | $184.00M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $250.87M 10-Q · filed 2019-08-06 |
| 2019-03-31 | $172.98M 10-K · filed 2020-05-18 |
| 2018-12-31 | $201.67M 10-Q · filed 2019-02-07 |
| 2018-09-30 | $168.17M 10-Q · filed 2018-11-08 |
| 2018-06-30 | $154.35M 10-Q · filed 2018-08-07 |
| 2018-03-31 | $119.10M 10-K · filed 2019-05-24 |
| 2017-12-31 | $137.98M 10-Q · filed 2018-02-13 |
| 2017-09-30 | $136.13M 10-Q · filed 2017-11-13 |
| 2017-06-30 | $163.40M 10-Q · filed 2017-08-10 |
| 2017-03-31 | $185.28M 10-K · filed 2018-06-07 |
| 2016-12-31 | $194.06M 10-Q · filed 2017-02-13 |
| 2016-09-30 | $2.00M 10-Q · filed 2016-12-09 |
| 2016-03-31 | $0.00 10-K · filed 2017-06-14 |